Search

Search Constraints

You searched for: Author/Creator Reinhardt, Lydia

Search Results

2. Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study. (November 2022)

3. Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases. (July 2021)

4. Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study. Issue 1 (13th November 2019)

5. Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients. Issue 1 (26th March 2020)

6. Dynarrestin, a Novel Inhibitor of Cytoplasmic Dynein. Issue 4 (19th April 2018)

7. Genetic characterization of advanced conjunctival melanoma and response to systemic treatment. (May 2022)

8. Hematological immune related adverse events after treatment with immune checkpoint inhibitors. (April 2021)

9. Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients. Issue 2 (22nd October 2020)

10. Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients. Issue 2 (22nd October 2020)